Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06890143 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 21, 2025 to Mar 22, 2025
    • Site details revised
    v3
  3. Interventions: Dapagliflozin+RAAS inhibitors ，then RAAS inhibitors alone (Drug), RAAS inhibitors alone ，then Dapagliflozin+RAAS inhibitors (Drug) to Dapagliflozin+Standard Treatment for 12 weeks,washout period for 4 weeks，then Standard Treatment alone for12 weeks (Drug), Standard…
    • Secondary endpoints: details revised at 1 of 6 entries
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a multicenter, randomized controlled crossover trial aimed to evaluate the efficacy and safety of dapagliflozin in the treatment of hereditary kidney disease with proteinuria in children
Trial Details
NCT Number NCT06890143
Lead Sponsor Children's Hospital of Fudan University
Collaborators: Guangzhou Women and Children's Medical Center, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Shandong Provincial Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Wuhan Children's Hospital, Xuzhou Children Hospital, First Affiliated Hospital, Sun Yat-Sen University, Kunming Children's Hospital, The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Nanjing Medical University, Zhengzhou Children's Hospital, China, Xiamen Women's and Children's Hospital, Guiyang Maternity and Child Health Care Hospital, Maternal and Child Health Care Hospital of Hainan Province, Children's Hospital of The Capital Institute of Pediatrics, Second Affiliated Hospital of Wenzhou Medical University, Xian Children's Hospital, The Second Hospital of Hebei Medical University, Wuxi Women's & Children's Hospital, First People's Hospital of Urumqi
Conditions
(from sponsor)		 Pediatric Hereditary Kidney Diseases
Related terms Proteinuria
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov